| Not Yet Recruiting | Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Cont NCT06974968 | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | Phase 2 |
| Not Yet Recruiting | Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly NCT07130617 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury NCT06976229 | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | Phase 1 |
| Recruiting | Bilateral Peribulbar Block for Cataract Surgery NCT07000669 | Tanta University | — |
| Recruiting | Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors NCT06639256 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Recruiting | Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients wit NCT06642428 | Jiuda Zhao | N/A |
| Not Yet Recruiting | AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC NCT06196814 | Hunan Province Tumor Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treat NCT06542549 | Anhui Provincial Hospital | Phase 3 |
| Not Yet Recruiting | Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer NCT06539091 | Anhui Provincial Hospital | Phase 3 |
| Recruiting | Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing M NCT07323251 | Beijing Tongren Hospital | N/A |
| Not Yet Recruiting | Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination NCT06237205 | Korea University Anam Hospital | Phase 2 |
| Recruiting | Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation NCT06243354 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Active Not Recruiting | Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Local NCT06281886 | Sun Yat-sen University | Phase 2 |
| Unknown | Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With NCT06205758 | Yi Han | — |
| Completed | A Study of GC101 TIL in Advanced Melanoma (BZ) NCT06120712 | Shanghai Juncell Therapeutics | Phase 1 / Phase 2 |
| Unknown | Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer NCT06284746 | Lin Chen | Phase 2 |
| Unknown | Study of the Clinical Benefits of Different Formulations of Amphotericin B NCT06123832 | Qianfoshan Hospital | — |
| Unknown | Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory NCT06271473 | Ain Shams University | N/A |
| Unknown | A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Tr NCT05993455 | Korea University Anam Hospital | Phase 2 |
| Unknown | Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors NCT05915481 | Peking University Third Hospital | Phase 1 / Phase 2 |
| Unknown | Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of NCT06317818 | Centre Hospitalier Universitaire de Liege | Phase 2 |
| Unknown | Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and NCT05913271 | Yi Han | — |
| Unknown | Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot NCT05999656 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Recruiting | Safety and Efficacy of Distal Radial Approach (SAFE-BOX) NCT05776550 | Yonsei University | — |
| Unknown | Efficacy of Myofunctional Therapy in Class II Patients NCT04975672 | Fundación Universitaria CIEO | N/A |
| Recruiting | PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study NCT05681689 | ARJ Medical, Inc. | Phase 3 |
| Completed | Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax NCT06044805 | Dinka Dugassa | Phase 4 |
| Completed | Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study NCT05556291 | Getz Pharma | — |
| Recruiting | PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study NCT05276557 | ARJ Medical, Inc. | Phase 3 |
| Unknown | A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB NCT06122454 | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Phase 1 / Phase 2 |
| Unknown | mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs NCT05686161 | Stemirna Therapeutics | Phase 3 |
| Completed | A Phase I Study of GC101 TIL in Advanced Solid Tumors NCT05417750 | Shanghai Juncell Therapeutics | Phase 1 |
| Unknown | New Generation mRNA Booster Vaccine Against Emerging VOCs NCT05580159 | Stemirna Therapeutics | Phase 3 |
| Completed | ETGBD in Surgically Unfit Patients With Both Choledocholithiasis and Cholecystolithiasis NCT05935969 | Seoul National University Hospital | — |
| Unknown | Dapagliflozin in Systemic Right Ventricle (DAPA-SERVE) NCT05717257 | Monaldi Hospital | Phase 4 |
| Unknown | Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disea NCT05430867 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Unknown | Pharmacokinetics and Pharmacodynamics of Linezolid Continuous and Intermittent Administration NCT05801484 | Cluj Municipal Clinical Hospital | N/A |
| Unknown | A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer NCT05430737 | West China Hospital | N/A |
| Unknown | Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments NCT05443217 | First Affiliated Hospital of Wenzhou Medical University | — |
| Recruiting | Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen NCT05731258 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Unknown | PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer NCT05325684 | The Affiliated Hospital of Qingdao University | Phase 1 / Phase 2 |
| Completed | Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) NCT05648799 | Geropharm | N/A |
| Unknown | Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma NCT06141109 | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Phase 1 / Phase 2 |
| Unknown | Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Stu NCT05172817 | Institute for Developing Science and Health Initiatives, Bangladesh | Phase 2 / Phase 3 |
| Unknown | Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B NCT04850950 | The First Affiliated Hospital of Zhengzhou University | Phase 4 |
| Completed | Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia NCT04773171 | The Hong Kong Polytechnic University | N/A |
| Completed | Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation NCT07021521 | Zhuji People's Hospital of Zhejiang Province | N/A |
| Completed | Multitarget Therapy for Idiopathic Membranous Nephropathy NCT04424862 | Beijing Friendship Hospital | Phase 4 |
| Recruiting | Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children NCT06530004 | The First Affiliated Hospital of Xiamen University | — |
| Completed | Apatinib for Inoperable Advanced Chondrosarcoma NCT04260113 | Peking University People's Hospital | N/A |
| Completed | GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose NCT03943875 | The University of Texas Medical Branch, Galveston | Phase 4 |
| Completed | Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South NCT05697887 | Number 2 Children's Hospital, Ho Chi Minh City | N/A |
| Unknown | RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma NCT03908138 | Shandong Provincial Hospital | Phase 4 |
| Unknown | The Effects Probiotic Has on Gastromicroecology and Combined With Quadruple Regimen for H Pylori Infection NCT03377933 | Yiqi Du | N/A |
| Unknown | Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema NCT04069780 | Azza Mohamed Ahmed Said | N/A |
| Completed | A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Di NCT05353686 | Pila Pharma | Phase 2 |
| Completed | The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitori NCT03790631 | University of Geneva, Switzerland | — |
| Active Not Recruiting | Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight NCT04002440 | University of California, San Diego | N/A |
| Recruiting | Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis NCT04592640 | The First Affiliated Hospital with Nanjing Medical University | EARLY_Phase 1 |
| Completed | Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer NCT03577743 | Assiut University | Phase 2 |
| Completed | Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnose NCT03796975 | Xijing Hospital | Phase 4 |
| Completed | TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer NCT05427305 | BioDlink Biopharm Co., Ltd. | Phase 3 |
| Unknown | Misodel or Angusta for Induction of Labour? NCT02693587 | Holbaek Sygehus | — |
| Completed | A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Da NCT02479412 | AstraZeneca | Phase 2 |
| Completed | Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use NCT03491371 | Peking University People's Hospital | N/A |
| Completed | Efficacy of US-guided TAP Block in Breast Reconstruction Surgery With Abdominal Myocutaneous Flap NCT03699267 | Instituto Portugues de Oncologia, Francisco Gentil, Porto | — |
| Completed | Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subj NCT02123134 | Kythera Biopharmaceuticals | Phase 3 |
| Terminated | RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP NCT02046590 | Erasme University Hospital | N/A |
| Completed | Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat NCT02035267 | Kythera Biopharmaceuticals | Phase 3 |
| Unknown | EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study NCT01902238 | Asan Medical Center | N/A |
| Completed | Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. NCT01692262 | AstraZeneca | Phase 1 |
| Completed | Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia NCT01623713 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 2 |
| Unknown | Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating NCT00967317 | Laboratorios Osorio de Moraes Ltda. | Phase 3 |
| Completed | Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung NCT01194453 | Sun Yat-sen University | Phase 2 |
| Unknown | Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety NCT00944268 | Ativus Farmaceutica Ltda | Phase 3 |
| Unknown | The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Tr NCT00564356 | Sheba Medical Center | N/A |
| Completed | A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer NCT00504192 | Soonchunhyang University Hospital | Phase 2 |